fibrinolysis

Also known as GO:0042730

Fibrinolysis is a process that prevents blood clots from growing and becoming problematic. Primary fibrinolysis is a normal body process, while secondary fibrinolysis is the breakdown of clots due to a medicine, a medical disorder, or some other cause.

In the Vinony graph

Vinony's link graph records 449 inbound references to fibrinolysis, and connects out to blood coagulation, Coagulation factor II, thrombin and thrombolysis.

It is catalogued under the topic Fibrinolytic system.

Vinony links it to 20 Wikipedia language editions.

Research

37,773 papers

Fibrinolysis in a nutshell.British journal of haematology · 2025
Fibrinolysis in Platelet Thrombi.International journal of molecular sciences · 2021
Altered Fibrinolysis in Hematological Malignances.Seminars in thrombosis and hemostasis · 2021
Impaired Fibrinolysis in the Antiphospholipid Syndrome.Seminars in thrombosis and hemostasis · 2021
Fibrinolysis.The New England journal of medicine · 1965

via PubMed

Wikidata facts

Instance of: biological process

Show 3 more facts

topic's main category: Category:Fibrinolytic system
exact match: purl.obolibrary.org/obo/GO_0042730
Commons category: Fibrinolytic system

Sources (3)

via Wikidata · CC0

~6 min read

Encyclopedic overview

7 sections

Contents

Physiology
Measurement
Role in disease
Pharmacology
Fibrinolytic enzymes
References
External links

In fibrinolysis, a fibrin clot, the product of coagulation, is broken down. Its main enzyme plasmin cuts the fibrin mesh at various places, leading to the production of circulating fragments that are cleared by other proteases or by the kidney and liver.

Excerpted from Wikipedia’s “fibrinolysis” article, available under the CC BY-SA 4.0 licence.